1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione

CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O

InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1

IQFYYKKMVGJFEH-XLPZGREQSA-N

thymidine; 50-89-5; deoxythymidine; 2'-Deoxythymidine; Thymidin; 5-Methyldeoxyuridine; Beta-Thymidine; DThyd; 5-Methyl-2'-deoxyuridine; Thymine-2-desoxyriboside; 5-Methyldeoxyurindine; Deoxyribothymidine; Thymine-2-deoxyriboside; Thyminedeoxyriboside; Thymine deoxyriboside; dThd; 2'-thymidine; Uridine, 2'-deoxy-5-methyl-; dT; Doxribtimine; thymine 2'-deoxyriboside; 2'-deoxy-5-methyluridine; AI3-52267; beta-D-Ribofuranoside, thymine-1 2-deoxy-; 157049-39-3; NSC 21548; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione; CHEBI:17748; 1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione; 2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-D-erythro-pentofuranosyl)-5-methyl-; Thymine 2-desoxyriboside; VC2W18DGKR; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione; 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; NSC-21548; [3H]-Thymidine; NCGC00142484-03; MFCD00006537; alpha-tritiated thymidine; 146183-25-7; 157049-40-6; THM; 1-(2-deoxy-beta-D-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione; 1-(2-Deoxy-beta-D-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione (Thymidine); 1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydro-furan-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; CCRIS 1283; EINECS 200-070-4; UNII-VC2W18DGKR; deoxyribosylthymine; 4qsv; Thymidinedeoxyriboside; 1w2g; Thymidine, >=99%; BDBM1; THYMIDINE [MI]; THYMIDINE [INCI]; Thymidine (8CI,9CI); DSSTox_CID_3661; DOXRIBTIMINE [INN]; bmse000244; Epitope ID:138113; THYMIDINE [MART.]; DOXRIBTIMINE [USAN]; EC 200-070-4; THYMIDINE [WHO-DD]; THYMIDINE [WHO-IP]; 2'-deoxy-5-methyl-Uridine; DSSTox_RID_77133; DSSTox_GSID_23661; SCHEMBL19894; 50-88-4; 2'-dT; CHEMBL52609; GTPL4718; DTXSID5023661; ZINC25672; IMPURITY C [EP IMPURITY]; ACT03217; HY-N1150; STR05630; Thymidine, >=99.0% (HPLC); Tox21_111560; HG1139; s4803; AKOS015895360; STAVUDINE IMPURITY C [WHO-IP]; thymine-1 2-deoxy-b-D-Ribofuranoside; AC-1475; AM83949; CCG-266886; CS-W019644; DB04485; CAS-50-89-5; DEOXYTHYMIDINE; 2'-DEOXYTHYMIDINE; NCGC00142484-01; 1-[(4S,2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-dihydropyri midine-2,4-dione; STAVUDINE IMPURITY C [EP IMPURITY]; Thymidine, Vetec(TM) reagent grade, 99%; DB-030432; ZIDOVUDINE IMPURITY E [EP IMPURITY]; T0233; thymine-1 2-deoxy-beta-delta-Ribofuranoside; MT-1621 COMPONENT 2'-DEOXYTHYMIDINE; 1-(2-Deoxy-A-D-ribofuranosyl)-5-methyluracil; 1-(2-Deoxy-beta-ribofuranosyl)-5-methyluracil; C00214; EN300-378408; A828337; Q422464; SR-01000883981; (1-[2-Deoxy-beta-D-ribofuranosyl]-5-methyluracil); 1-(2-Deoxy-.beta.-D-ribofuranosyl)-5-methyluracil; J-700251; SR-01000883981-1; BRD-K28309349-001-02-4; Q27124084; D7E43A69-265B-4DAA-BC8F-193FB357140F; Thymidine, powder, BioReagent, suitable for cell culture; Z1741976665; 1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione; 1-(2-Deoxy-b-D-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione; 1-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione; 1-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione; 1-(2-DEOXY-.BETA.-D-ERYTHRO-PENTOFURANOSYL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE [WHO-IP]; 1-(2-Deoxy-beta-D-ribofuranosyl)-5-methyluracil; 1-(2-Deoxy-beta-D-ribofuranosyl)thymine; Thymine deoxyriboside; 2'-Deoxythymidine; 5-Methyldeoxyuridine; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione; 1211376-53-2